Last reviewed · How we verify
Nicotine dependence
Approved treatments
- Wellbutrin · GSK (GlaxoSmithKline)
Norepinephrine-dopamine reuptake inhibitor (NDRI) that treats depression and aids smoking cessation without serotonergic side effects. - Nicorette · Sanofi
- Wellbutrin · Mclean Hospital
- Elontril · Boehringer Ingelheim
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nicotine dependence patent landscape — cliff calendar, originator estates, attackable patents
- Nicotine dependence treatment landscape brief
- Nicotine dependence treatment updates RSS
Frequently asked questions about Nicotine dependence
What drugs treat Nicotine dependence?
Tracked treatments include Wellbutrin, Nicorette, Elontril.
What is the treatment for Nicotine dependence?
Standard treatment for Nicotine dependence includes Wellbutrin, Nicorette, Elontril. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nicotine dependence patent cliff · Nicotine dependence CI report
- Treatment: Wellbutrin · GSK (GlaxoSmithKline)
- Treatment: Nicorette · Sanofi
- Treatment: Wellbutrin · Mclean Hospital
- Treatment: Elontril · Boehringer Ingelheim
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing